BMI1 and neoplasm: Furthermore, our data demonstrated that the expression level of Bmi1 of the tumor from the shRNA-CCAT1 group was lower compared with the control group with immunochemistry analysis and miRNA-218-5p inhibitor abrogated the decrease (Figures 8c and d)